Chiral discrimination and enantioselective analysis of drugs: an overview.
about
Comparison of the enantiomers of (+/-)-doxanthrine, a high efficacy full dopamine D(1) receptor agonist, and a reversal of enantioselectivity at D(1) versus alpha(2C) adrenergic receptorsStereoselective interaction of ketoprofen enantiomers with β-cyclodextrin: ground state binding and photochemistry.Chiral chromatographic resolution of antiepileptic drugs and their metabolites: a challenge from the optimization to the application.A sensitive LC-MS/MS method for simultaneous determination of R-bambuterol and its active metabolite R-terbutaline in human plasma and urine with application to a clinical pharmacokinetic study.Chiral determination of antidepressant drugs and their metabolites in biological samples.Molecular imprinting science and technology: a survey of the literature for the years 2004-2011.Recent Advances in Stereoselective Drug Targeting.Recent Advances in Multinuclear NMR Spectroscopy for Chiral Recognition of Organic Compounds.Central-to-axial chirality transfer revealed by liquid crystals: a combined experimental and computational approach for the determination of absolute configuration of carboxylic acids with an α chirality centre.New insight into the stereoselective interactions of quinine and quinidine, with bovine serum albumin.Electrospinning of magnetic cellulose tris-(4-methylbenzoate) microparticles for enantioselective adsorption of racemic drug.Betamethasone-based chiral electrochemical sensor coupled to chemometric methods for determination of mandelic acid enantiomers.Speeding up Viedma ripening.Significance and challenges of stereoselectivity assessing methods in drug metabolism.Effects of solvent on inclusion complexation of a chiral dipeptide toward racemic BINOL.Toward Fluorescence-Based High-Throughput Screening for Enantiomeric Excess in Amines and Amino Acid Derivatives.Determination of enantiomeric excess in amine derivatives with molecular self-assemblies.The electrochemical discrimination of pinene enantiomers by a cyclodextrin metal-organic framework.Chiral recognition of imperanene enantiomers by various cyclodextrins: a capillary electrophoresis and NMR spectroscopy study.Enantioselective analysis of melagatran via an LSPR biosensor integrated with a microfluidic chip.Stereospecific recognition and quantitative structure-activity relationship between antibodies and enantiomers: ofloxacin as a model hapten.Chiral recognition of L-tryptophan with beta-cyclodextrin-modified biomimetic single nanochannel.Theoretical and Molecular Docking Study of Ketoconazole on Heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin as Chiral Selector.Novel chiral recognition beyond the limitation due to the law of mass action: highly enantioselective chiral sensing based on non-linear response in phase transition eventsChiral Separation in Preparative Scale: A Brief Overview of Membranes as Tools for Enantiomeric SeparationEnantioselective Recognition of Proline Enantiomers Using Sulfhydryl-modified Self-assembled Gold ElectrodesZirconia-Based Stationary Phases for Chiral Separation: Mini ReviewChiral pharmaceuticals in the environmentChiral Recognition by Fluorescence: One Measurement for Two Parameters
P2860
Q24657515-5E8C69F7-0695-46CF-A9FC-F8D1B466BC81Q33729430-E0D1618B-BB60-4536-A63D-72D309F79D51Q34941977-F8F45B60-BF56-459A-B943-7E5C0E8AA92FQ35072273-59E87758-0858-42B2-A11B-81D21E43C192Q37810213-8B57B99F-D3ED-481D-9031-8E0E754EF5AAQ38202089-575A28B8-0650-4D78-AA9D-4D92AE1559C4Q38533893-673080A1-C1B1-4BC5-B260-00D3CDB76E7EQ39126554-7C44394C-8CC1-4848-8534-5D69E0A342D9Q44319317-5D49B01A-AB0B-4F98-9EE0-EC696FE0A59FQ45570638-D31160F6-350F-498C-B08F-63A064CBA0A6Q47622911-555922DB-089D-4C45-B467-9D4CF3A3EFD4Q47778542-BDF6A06E-9437-44B4-8286-C94ABBB1DAF7Q48311648-A445FB7B-5B77-41F0-8D7D-F6C9C34D68DCQ49538988-B82E00DF-11E9-4651-87B4-3672204DC764Q50214850-E90E5927-8AD7-4A24-88BA-6C3408B23924Q50226428-92D65D45-4375-4784-933B-DDAD12C0FA21Q50278700-A65057B4-CDE4-4326-8DD0-92FFF60E5D4AQ50733131-445D36CD-BF24-4A8F-895B-12FF0FAB4ADCQ51360634-73B87300-3667-4C10-89D1-BF833DD3AF83Q51538439-FCA0AC52-543F-4E53-BF46-4480630C35F5Q53349074-2D542B9A-D6E6-4B86-9143-7F0F0512854CQ53634762-DBBDB5F9-F62F-4BC7-A449-E4233A68755DQ53779028-F8DE709F-CFC6-493C-A795-B4B7FCD582EEQ57363781-62BD2F07-A032-4E49-A16D-8199DECDDDE9Q57372391-AA50C056-6474-4DF4-BDE3-0A19384FC763Q58168484-39492928-63F9-4D29-8B41-5F1B1DBD336AQ58299011-5D415621-17F5-47BC-B8F0-8C866FEE1BC1Q58875580-A4AC3639-248E-43DB-B791-E95D15514CB8Q59043532-13DB18C0-68AD-411E-9F0E-4FD88A86F59B
P2860
Chiral discrimination and enantioselective analysis of drugs: an overview.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chiral discrimination and enantioselective analysis of drugs: an overview.
@ast
Chiral discrimination and enantioselective analysis of drugs: an overview.
@en
type
label
Chiral discrimination and enantioselective analysis of drugs: an overview.
@ast
Chiral discrimination and enantioselective analysis of drugs: an overview.
@en
prefLabel
Chiral discrimination and enantioselective analysis of drugs: an overview.
@ast
Chiral discrimination and enantioselective analysis of drugs: an overview.
@en
P356
P1476
Chiral discrimination and enantioselective analysis of drugs: an overview.
@en
P2093
Emad L Izake
P304
P356
10.1002/JPS.20820
P407
P577
2007-07-01T00:00:00Z